SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-22-021191
Filing Date
2022-08-03
Accepted
2022-08-03 17:14:12
Documents
16
Period of Report
2022-08-03

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 20278
2 form6-k_001.jpg GRAPHIC 7492
3 ex99-1.htm EX-99.1 358587
4 ex99-1_001.jpg GRAPHIC 54013
5 ex99-2.htm EX-99.2 269854
6 ex99-2_001.jpg GRAPHIC 7492
7 ex99-2_002.jpg GRAPHIC 293408
8 ex99-2_003.jpg GRAPHIC 29474
9 ex99-2_004.jpg GRAPHIC 61348
10 ex99-3.htm EX-99.3 2069
11 ex99-3_001.jpg GRAPHIC 308769
12 ex99-3_002.jpg GRAPHIC 67455
13 ex99-4.htm EX-99.4 3106
14 ex99-4_001.jpg GRAPHIC 309128
15 ex99-4_002.jpg GRAPHIC 70352
16 ex99-4_003.jpg GRAPHIC 162755
  Complete submission text file 0001493152-22-021191.txt   2544875
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 221133635
SIC: 2834 Pharmaceutical Preparations